These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 1914341)

  • 21. Hepatic microvasculature in liver injury.
    DeLeve LD
    Semin Liver Dis; 2007 Nov; 27(4):390-400. PubMed ID: 17979075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrahepatic circulation in liver disease.
    Huet PM; Pomier-Layrargues G; Villeneuve JP; Varin F; Viallet A
    Semin Liver Dis; 1986 Nov; 6(4):277-86. PubMed ID: 3544221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multiscale modelling approach to assess the impact of metabolic zonation and microperfusion on the hepatic carbohydrate metabolism.
    Berndt N; Horger MS; Bulik S; Holzhütter HG
    PLoS Comput Biol; 2018 Feb; 14(2):e1006005. PubMed ID: 29447152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of retrograde flow on measured blood volume, Disse space, intracellular water space and drug extraction in the perfused rat liver: characterization by the multiple indicator dilution technique.
    Xu N; Chow A; Goresky CA; Pang KS
    J Pharmacol Exp Ther; 1990 Sep; 254(3):914-25. PubMed ID: 2395120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of Hepatic Impairment and Implications for Pharmacokinetics of Substance Use Treatment.
    Talal AH; Venuto CS; Younis I
    Clin Pharmacol Drug Dev; 2017 Mar; 6(2):206-212. PubMed ID: 28263464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined hepatic arterial-portal venous and hepatic arterial-hepatic venous perfusions to probe the abundance of drug metabolizing activities: perihepatic venous O-deethylation activity for phenacetin and periportal sulfation activity for acetaminophen in the once-through rat liver preparation.
    Pang KS; Cherry WF; Accaputo J; Schwab AJ; Goresky CA
    J Pharmacol Exp Ther; 1988 Nov; 247(2):690-700. PubMed ID: 3183964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of pharmacokinetic models of hepatic elimination.
    Morgan DJ; Smallwood RA
    Clin Pharmacokinet; 1990 Jan; 18(1):61-76. PubMed ID: 2178850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Theophylline pharmacokinetics in patients with liver diseases with reference to estimated hepatic blood flow].
    Nomura F; Ohnishi K; Ohto M; Takeda Y; Rikihisa T; Kanakubo Y
    Rinsho Byori; 1991 Oct; 39(10):1093-7. PubMed ID: 1762184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Old age and the hepatic sinusoid.
    Le Couteur DG; Warren A; Cogger VC; Smedsrød B; Sørensen KK; De Cabo R; Fraser R; McCuskey RS
    Anat Rec (Hoboken); 2008 Jun; 291(6):672-83. PubMed ID: 18484614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver hemodynamics and portacaval shunt.
    Thiel H
    Surg Gynecol Obstet; 1980 Apr; 150(4):587-92. PubMed ID: 6987756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Drug therapy in liver disease].
    Meier PJ
    Schweiz Med Wochenschr; 1982 Feb; 112(8):258-63. PubMed ID: 7043727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The hepatic sinusoid is not well-stirred: estimation of the degree of axial mixing by analysis of lobular concentration gradients formed during uptake of thyroxine by the perfused rat liver.
    Weisiger RA; Mendel CM; Cavalieri RR
    J Pharm Sci; 1986 Mar; 75(3):233-7. PubMed ID: 3701605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose- and time-dependent effects of ethanol on functional and structural aspects of the liver sinusoid in the mouse.
    Sarphie G; D'Souza NB; Van Thiel DH; Hill D; McClain CJ; Deaciuc IV
    Alcohol Clin Exp Res; 1997 Sep; 21(6):1128-36. PubMed ID: 9309327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of hepatic insufficiency in pharmacokinetics of drugs: example for an anthranilic diuretic.
    Dreux C; Passa P; Halter D
    Methods Find Exp Clin Pharmacol; 1979 Dec; 1(5):289-96. PubMed ID: 552592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-function relationship in secondary biliary cirrhosis in the rat. Stereologic and hemodynamic characterization of a model.
    Ohara N; Schaffner T; Reichen J
    J Hepatol; 1993 Feb; 17(2):155-62. PubMed ID: 8445230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of hepatic arterial flow on portal venous and hepatic venous wedged pressure in the isolated perfused CCl4-cirrhotic liver.
    Zipprich A; Loureiro-Silva MR; D'Silva I; Groszmann RJ
    Am J Physiol Gastrointest Liver Physiol; 2008 Jul; 295(1):G197-G202. PubMed ID: 18497333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular drug therapy in patients with hepatic diseases and patients with congestive heart failure.
    Sokol SI; Cheng A; Frishman WH; Kaza CS
    J Clin Pharmacol; 2000 Jan; 40(1):11-30. PubMed ID: 10631618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presinusoidal and proximal intrasinusoidal confluence of hepatic artery and portal vein in rat liver: functional evidence by orthograde and retrograde bivascular perfusion.
    Watanabe Y; Püschel GP; Gardemann A; Jungermann K
    Hepatology; 1994 May; 19(5):1198-207. PubMed ID: 8175142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bilirubin metabolism in liver cirrhosis].
    Ohkubo A
    Nihon Rinsho; 1994 Jan; 52(1):138-44. PubMed ID: 8114283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenteric venous hypertension: importance after portal systemic shunting?
    Landreneau RJ; Horton JW; McClelland RN
    Surgery; 1989 Jul; 106(1):11-20. PubMed ID: 2740986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.